Company / Accounts Receivable
ICU Medical Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$180.5M
FY2025
5-year range
$105.9M / $221.7M
FY2021-FY2025
Trend
-1.3%
vs FY2024
Sector context
#75 of 138
Health Care
What the data says
At $181M, ICU Medical's accounts receivable ranks #75 of 138 in the Health Care sector. Accounts Receivable has fluctuated over the past 10 years, ranging from $56M in FY2016 to $222M in FY2022.
Based on SEC 10-K filings.
$181M in FY2025 with a 5-year CAGR of +7.8%.
Improved from $162M to $181M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -6.6%
- 5-Year CAGR
- +7.8%
- 10-Year CAGR
- -
Sector benchmark
#75 of 138 in Health CareTop 54% of 138This company $180.5M Sector average $1.3B
▼
-86.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.8%, indicating consistent growth.
- In FY2025, accounts receivable decreased 1.3% year-over-year.
- Ranks #75 out of 138 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $180.5M | -1.3% |
| FY2024 | $182.8M | +13.2% |
| FY2023 | $161.6M | -27.1% |
| FY2022 | $221.7M | +109.4% |
| FY2021 | $105.9M | -14.7% |
| FY2020 | $124.1M | -38.6% |
| FY2019 | $202.2M | +14.7% |
| FY2018 | $176.3M | +56.4% |
| FY2017 | $112.7M | +100.7% |
| FY2016 | $56.2M | -2.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026